Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg

JR Zalcberg, Jaap Verweij, PG Casali, A le Cesne, P Reichardt, JY Blay, M Schlemmer, M Glabbeke, M Brown, IR Judson

Research output: Contribution to journalArticleAcademicpeer-review

334 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1751-1757
Number of pages7
JournalEuropean Journal of Cancer
Issue number12
Publication statusPublished - 2005
Externally publishedYes

Research programs

  • EMC MM-03-86-08

Cite this